Structure-Property Relationship Studies of Influenza A Virus AM2-S31N Proton Channel Blockers

Area of Science:

• Virology
• Medicinal Chemistry
• Drug Discovery

Background:

• Influenza A viruses frequently develop resistance to existing antivirals.
• The S31N mutation in the M2 gene of influenza A viruses presents a significant target for novel antiviral therapies.
• Oseltamivir-resistant strains necessitate the development of new treatment options.

Purpose of the Study:

• To identify novel AM2-S31N channel blockers with improved pharmacokinetic properties.
• To evaluate the antiviral activity of lead compounds against oseltamivir-sensitive and -resistant influenza A viruses.
• To investigate the structure-property relationships of AM2-S31N inhibitors.

Main Methods:

• Structure-property relationship studies were conducted on AM2-S31N inhibitors.
• Microsomal stability and membrane permeability assays were performed.
• Antiviral activity was assessed using EC50 values and selectivity indices against influenza A virus strains (H1N1, H3N2).
• Inhibition of viral replication was evaluated at various multiplicities of infection.

Main Results:

• Two lead compounds, 10d and 10e, exhibited high microsomal stability (T1/2 > 145 min) and membrane permeability (>200 nm/s).
• Both compounds effectively inhibited oseltamivir-sensitive and -resistant influenza A viruses (H1N1, H3N2) with EC50 values from 0.4 to 2.8 μM and a selectivity index >100.
• Compound 10e demonstrated efficacy in inhibiting viral replication across a broad range of multiplicities of infection (10^2-10^6 pfu/mL) and was not cell-type dependent.

Conclusions:

• Compounds 10d and 10e are promising lead candidates for developing new antiviral drugs against drug-resistant influenza A viruses.
• The identified compounds possess favorable stability and permeability profiles for further therapeutic development.
• This study highlights the potential of AM2-S31N channel blockers as a viable strategy against resistant influenza strains.